MedPath

MEasurement by a Numerical Approach of BREAst Volume

Not Applicable
Completed
Conditions
Breast Asymmetry, 3D
Registration Number
NCT03715738
Lead Sponsor
University Hospital, Angers
Brief Summary

Breast asymmetry is a rare in plastic surgery. In majority of cases, it is idiopathic.

In cases that are poorly tolerated physically (vertebral imbalance, posture disorders) or psychologically, the decision to perform breast symmetrization surgery can be made. It is recommended to do this surgery after a slimming treatment if the woman is overweight or after pregnancy that causes a change in the structure and volume of the chest. In fact, the weight variations deteriorate the long-term result.

However, this surgical management remains difficult. In fact, the volume to be removed (unilateral breast reduction) to be symmetrized is a function of the volume of the contralateral breast and the preoperative drawings are made while standing. Currently, the evaluation of the volume to be removed remains subjective and is based on the experience of the surgeon. In addition, intraoperatively, this evaluation is also subjective because the patient is lying down which changes the position of the anatomical landmarks: the optimization of the symmetrization is only possible by the eye and the touch.

No measuring device is currently used to assess the difference in volume between the 2 breasts and guide the surgeon in the volume (or weight) to remove. It is therefore sometimes necessary to perform a second intervention in case of residual postoperative asymmetry.

Primary objective :

To study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO).

Second objective : To study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patients referred for uni / bilateral breast reduction as part of an indication of surgical management.
  • Major patients.
  • Patients affiliated or beneficiaries of a social security scheme
  • Patients who have signed prior informed consent.
Exclusion Criteria
  • Protected patients (pregnant, parturient and lactating women, persons deprived of their liberty by an administrative or judicial decision, persons undergoing psychiatric care under duress, minors, adults over the age of 18) legal protection measure or unable to express their consent).
  • Patients unfit to understand the objectives or instructions of the study.
  • Patients in an exclusion period relative to another interventional study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
association between weight and volume adjusted to the density of the gland measured by electronic palpationone year

To study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO).

Primary judgment criterion:

Coefficient associated with volume variation in the linear regression model (model 1) explaining weight by volume variation and density measured by electronic palpation.

Secondary Outcome Measures
NameTimeMethod
association between weight and volume adjusted to the density of the gland estimated by manual palpationone year

To study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5).

Secondary judgment criterion 1:

Coefficient associated with volume variation in the linear regression model (Model 2) explaining weight by volume variation and estimated density by manual palpation.

comparison of models 1 and 2one year

Comparison of models 1 and 2 (estimated density by manual palpation or measured by electronic method), to see if one model is better than the other.

Secondary judgment criterion 2:

Akaike Criterion

Trial Locations

Locations (1)

CHU Angers

🇫🇷

Angers, Maine Et Loire, France

© Copyright 2025. All Rights Reserved by MedPath